Cann American Corp Stock Fundamentals

CNNA Stock  USD 0  0.0001  3.03%   
Cann American Corp fundamentals help investors to digest information that contributes to Cann American's financial success or failures. It also enables traders to predict the movement of Cann Pink Sheet. The fundamental analysis module provides a way to measure Cann American's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cann American pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cann American Corp Company Current Valuation Analysis

Cann American's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Cann American Current Valuation

    
  48  
Most of Cann American's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cann American Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Cann American Corp has a Current Valuation of 48.0. This is 100.0% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 100.0% higher than that of the company.

Cann American Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cann American's current stock value. Our valuation model uses many indicators to compare Cann American value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cann American competition to find correlations between indicators driving Cann American's intrinsic value. More Info.
Cann American Corp is rated second in return on equity category among its peers. It is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cann American by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cann American's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Cann Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cann American's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Cann American could also be used in its relative valuation, which is a method of valuing Cann American by comparing valuation metrics of similar companies.
Cann American is currently under evaluation in current valuation category among its peers.

Cann Fundamentals

About Cann American Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cann American Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cann American using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cann American Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Cann American Corp., a development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries. Cann American Corp. was founded in 2004 and is based in Cloverdale, California. CANN AMERICAN operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Cann Pink Sheet

Cann American financial ratios help investors to determine whether Cann Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cann with respect to the benefits of owning Cann American security.